TrialEuropean journal of drug metabolism and pharmacokinetics2025

Bioequivalence and Safety of Bilastine 20 mg Administered in Three Eight-Hourly Dose Versus a Single Daily Dose: A Randomized Two-Treatment, Two-Period, Cross-Over Comparative Study.

Ekta Sinha et al.PubMed ↗Publisher ↗

No numbers read from the abstract.